Drug Manufacturers - Specialty & Generic | Healthcare
Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers API products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, sulfadoxine, tenofovir alafenamide hemifumarate, and tenofovir disoproxil fumarate. It also provides intermediates, such as 2-dibutylamino-1-(2,7-dichloro-9H-fluorine-4-yl)-ethanol; 4,6-dichloro-5-methoxy pyrimidine; 4,7 dichloroquinoline; and ortho phenoxy methane sulfonanilide, tenofovir alafenamide base, and tenofovir disoproxil base. In addition, the company offers specialty chemicals comprising l(+)menthol; 2,3-dihydrophthalazine-1, 4-dione or phthalazine-1,4-dione; and 4-cynoethyl-2-methy phenol; bictegravir Na, aripiprazole, risperidone, olanzapine, and etodolac; and develops tafenoquine succinate and pretomanid. Further, it manufactures organic and inorganic chemicals, and heavy chemicals. The company was incorporated in 1972 and is based in Mumbai, India.
Market Cap
1327036288
Current Price
83.84
52 Week Range
70.1 - 144.99
Previous Close
82.98
Open
83.98
Sector
Healthcare
Address
Rupam Building, 3rd Floor 239, P D’ Mello Road Near GPO, Mumbai, 400001, India
Phone
+91-22626-16200
Fax
+91-22626-19090
Website
https://www.mangalamdrugs.com
Day Low
82.11
Day High
84.89
Dividend Yield
PE Ratio
19.452436
Earnings Per Share
4.31
Beta
-0.064
EBITDA
358228000
Book Value
100.323
EPS
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Govardhan Murlidhar Dhoot | Chairman & MD | 71 | 1953 |
Dr. Kamal Ishvarlal Vashi | President | 44 | 1980 |
Ms. Krishnapriya Nawal | Chief Operating Officer | 39 | 1985 |
Mr. Brijmohan Murlidhar Dhoot | Whole-Time Director | 73 | 1951 |
Ms. Anuradha Pandey | Company Secretary & Compliance Officer | 31 | 1993 |
Mr. Yaduraj Dhoot | Head of Purchase | 24 | 2000 |
Ms. Mansi Sidhinath Pathak | Senior Manager | 45 | 1979 |
Mr. Rakesh Sakikram Srivastava | General Manager | 50 | 1974 |
Dr. Bhanvesh Dinesh Naik | General Manager | 45 | 1979 |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.